BioNano Genomics, Inc. WT EXP 082123 – NASDAQ:BNGOW

Financial Health
0
1
2
3
4
5
6
7
8
9

BioNano Genomics, Inc. WT EXP 082123 stock price monthly change

-90.00%
month

BioNano Genomics, Inc. WT EXP 082123 stock price quarterly change

-91.58%
quarter

BioNano Genomics, Inc. WT EXP 082123 stock price yearly change

-99.18%
year

BioNano Genomics, Inc. WT EXP 082123 key metrics

Market Cap
 N/A
Enterprise value
 28.01M
P/E
 -0.16
EV/Sales
 1.00
EV/EBITDA
 -0.23
Price/Sales
 0.77
Price/Book
 0.08
PEG ratio
 1.47
EPS
 -6.02
Revenue
 37.47M
EBITDA
 -107.46M
Income
 -226.79M
Revenue Q/Q
 18.26%
Revenue Y/Y
 26.92%
Profit margin
 -476.93%
Oper. margin
 -473.7%
Gross margin
 21.39%
EBIT margin
 -473.7%
EBITDA margin
 -286.81%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

BioNano Genomics, Inc. WT EXP 082123 stock price history

BioNano Genomics, Inc. WT EXP 082123 stock forecast

BioNano Genomics, Inc. WT EXP 082123 financial statements

Profit Margin

BioNano Genomics, Inc. WT EXP 082123 (NASDAQ:BNGOW): Profit margin
Jun 2023 8.66M -38.91M -449.23%
Sep 2023 9.31M -112.56M -1208.05%
Dec 2023 10.72M -43.89M -409.39%
Mar 2024 8.76M -31.42M -358.33%
BNGOW income statement history

Debt to Assets

BioNano Genomics, Inc. WT EXP 082123 (NASDAQ:BNGOW): Debt to assets
Jun 2023 271381000 56.62M 20.87%
Sep 2023 181904000 62.90M 34.58%
Dec 2023 214404000 118.24M 55.15%
Mar 2024 157995000 75.22M 47.61%
BNGOW balance sheet history

Cash Flow

BioNano Genomics, Inc. WT EXP 082123 (NASDAQ:BNGOW): Cash Flow
Jun 2023 -36.69M 29.57M 17.88M
Sep 2023 -26.29M 33.42M 12.58M
Dec 2023 -34.3M -55.37M 73.00M
Mar 2024 -28.13M 47.58M -21.61M
BNGOW cash flow history

BioNano Genomics, Inc. WT EXP 082123 other data

BioNano Genomics, Inc. WT EXP 082123
Hedge Funds Holdings Q1 2022

0.03% -0.05%
of BNGOW is owned by hedge funds
1 -2
hedge funds hold BNGOW stock
80.76K -131.91K
shares is hold by hedge funds
BNGOW hedge funds holdings changes

BioNano Genomics, Inc. WT EXP 082123
Insider Trading

BioNano Genomics, Inc. WT EXP 082123 (NASDAQ:BNGOW): Insider trades (number of shares)
Period Buy Sel
Nov 2021 5025 0
May 2022 10000 0
Aug 2022 0 20000
Transaction Date Insider Security Shares Price per share Total value Source
Option
LINNEY YVONNE director
 Common Stock 20,000 $0.38 $7,600
Option
LINNEY YVONNE director
 Stock Option (Right to Buy) 20,000 $0.38 $7,600
Sale
LINNEY YVONNE director
 Common Stock 20,000 $3.62 $72,400
Option
BARKER DAVID L director
 Stock Option (Right to Buy) 44,470 $0.51 $22,680
Option
BARKER DAVID L director
 Common Stock 44,470 $0.51 $22,680
Purchase
BARKER DAVID L director
 Common Stock 10,000 $1.6 $16,000
Option
STEWART CHRISTOPHER P. officer: Chief Financial Officer
 Stock Option (Right to Buy) 60,000 $0.56 $33,600
Option
STEWART CHRISTOPHER P. officer: Chief Financial Officer
 Common Stock 60,000 $0.56 $33,600
Purchase
HOLMLIN R. ERIK director, officer: President an..
 Common Stock 5,025 $3.99 $20,025
Option
STEWART CHRISTOPHER P. officer: Chief Financial Officer
 Stock Option (Right to Buy) 22,500 $0.56 $12,600
BNGOW insider trading transactions

Frequently Asked Questions (FAQ)

  • When is BioNano Genomics, Inc. WT EXP 082123's next earnings date?

    Unfortunately, BioNano Genomics, Inc. WT EXP 082123's (BNGOW) next earnings date is currently unknown.

  • Does BioNano Genomics, Inc. WT EXP 082123 pay dividends?

    No, BioNano Genomics, Inc. WT EXP 082123 does not pay dividends.

  • What is BioNano Genomics, Inc. WT EXP 082123's stock symbol?

    BioNano Genomics, Inc. WT EXP 082123 is traded on the NASDAQ under the ticker symbol "BNGOW".

  • How do i buy shares of BioNano Genomics, Inc. WT EXP 082123?

    Shares of BioNano Genomics, Inc. WT EXP 082123 can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When BioNano Genomics, Inc. WT EXP 082123 went public?

    BioNano Genomics, Inc. WT EXP 082123 is publicly traded company for more then 7 years since IPO on 21 Sep 2018.

BioNano Genomics, Inc. WT EXP 082123 company profile:

BioNano Genomics, Inc. WT EXP 082123

Exchange:

NASDAQ

Full time employees:

0

Industry:

Sector:


,

CIK: 0001411690
:
CUSIP: 09075F115